IMDNA provides scientific, technical, and non-regulatory support for laboratories planning and conducting method verification or analytical validation activities. Support can include study-design assistance, draft protocols and worksheets, QC and reference materials, comparison-study planning, precision and bias studies, reportable-range assessment, detection-capability studies, analytical specificity and interference assessment, technical data review, troubleshooting, optimization, and implementation support.
The required study scope depends on the method, intended use, laboratory setting, test-system status, modifications, specimen type, and applicable requirements. IMDNA can help organize the scientific and technical work while the laboratory retains responsibility for determining applicable requirements, approving protocols and acceptance criteria, executing and documenting required studies, interpreting results, and authorizing method use.
For applicable U.S. nonwaived clinical laboratory testing, 42 CFR §493.1253 distinguishes verification of performance specifications for unmodified FDA-cleared or approved test systems from establishment of performance specifications for modified, laboratory-developed, or other applicable systems. CLSI likewise distinguishes user verification of previously established claims from broader performance-establishment studies. The terminology and study design should therefore match the actual method and intended use.
Clarify whether the method is unmodified, transferred, modified, laboratory-developed, quantitative, qualitative, multiplex, or otherwise configured.
Identify which performance characteristics are applicable and what evidence is needed for the intended use.
Define measurable technical criteria before study execution using applicable claims, laboratory needs, literature, reference materials, or other justified sources.
Use samples, controls, standards, or reference materials that adequately challenge the method across the relevant operating range and matrix.
The laboratory reviews the completed evidence and determines whether the method is acceptable for its intended use.
IMDNA can support individual study components or a coordinated technical package, depending on the laboratory's method and project needs.
Help define study objectives, performance characteristics, sample needs, replicate structure, runs, operators, instruments, concentrations, and technical endpoints.
Provide draft verification, validation, precision, comparison, range, sensitivity, specificity, interference, or other study protocols and supporting worksheets where appropriate.
Assist the laboratory in organizing proposed technical acceptance criteria based on applicable manufacturer claims, intended use, laboratory needs, recognized guidance, or scientific justification.
Where appropriate and available, help identify or provide controls, standards, calibrators, reference materials, contrived materials, or other study-support materials.
Support planning for method-comparison or agreement studies using patient or other representative materials and assist with data organization and technical review.
Help organize repeatability, within-run, between-run, day-to-day, operator, instrument, or lot studies according to the intended method and study objective.
Support technical planning for comparison against assigned values, reference materials, comparator methods, or other justified benchmarks.
Help plan evaluation across the method's expected measuring or reportable range and assess whether performance remains suitable across that interval.
Support study planning for limit of blank, limit of detection, limit of quantitation, or qualitative low-level detection where relevant to the method.
Help identify potential cross-reactants, matrix effects, endogenous/exogenous interferents, related targets, competing analytes, or other method-specific challenges.
Assist with review of control behavior, precision, agreement, outliers, discordance, range, sensitivity, specificity, and other technical observations.
Help investigate failed criteria or unstable performance and recommend technically justified optimization or additional studies where appropriate.
IMDNA's support model helps the laboratory organize the scientific work from method review through study execution, data assessment, troubleshooting, and implementation.
The study framework should match the regulatory and scientific status of the method. The table below is a general educational framework and does not replace the laboratory's own determination of applicable requirements.
| Method Situation | General Technical Approach | IMDNA Support May Include |
|---|---|---|
| Unmodified FDA-cleared / approved nonwaived method | Verify applicable performance specifications in the laboratory before reporting patient results. CMS materials identify accuracy, precision, reportable range, and verification of reference intervals as core verification topics for applicable systems. | Protocol templates, QC/reference materials, precision study support, comparison/accuracy study support, range study support, data review, troubleshooting. |
| Modified method | Establish applicable performance specifications for the modified configuration before clinical use. | Analytical study planning, sensitivity/specificity studies, precision, range, interference, comparison studies, controls, optimization, documentation support. |
| Laboratory-developed method | Establish and document applicable performance characteristics for the laboratory's intended use. | Validation-plan support, precision, bias/agreement, detection capability, analytical specificity/interference, range, controls, data review, troubleshooting. |
| Transferred method | Assess whether performance remains acceptable in the receiving laboratory and determine whether additional verification or validation is needed. | Gap assessment, cross-validation/comparison planning, shared materials, technical review, workflow transfer support. |
| New instrument / major workflow change | Determine whether the change could materially affect method performance and evaluate accordingly. | Comparison study, precision checks, range/sensitivity review, control strategy, workflow evaluation, technical troubleshooting. |
Not every characteristic applies identically to every method. Study selection should follow the assay type and intended use rather than applying one universal validation package.
Evaluate agreement with a comparator, assigned value, reference material, or other justified benchmark where appropriate.
Assess repeatability and other relevant sources of imprecision such as run, day, operator, instrument, or reagent lot.
Estimate systematic difference from assigned values or comparator methods where a suitable reference framework exists.
Evaluate the interval over which results can be reported or measured with acceptable performance.
Assess low-level detection or quantification limits where relevant to the intended method.
Evaluate target selectivity, cross-reactivity, related analytes/organisms, sequence homology, or nonspecific responses as appropriate.
Challenge relevant endogenous or exogenous substances, sample conditions, inhibitors, or matrix effects that could influence results.
Where applicable, verify or establish reference-interval or interpretive-range considerations using a scientifically appropriate approach.
Quantitative measurement procedures often require a combination of precision, bias/agreement, range, sensitivity, linearity or other quantitative-performance studies depending on the intended use.
Qualitative methods require performance studies appropriate to categorical output and expected clinical or research use rather than simply borrowing quantitative-method designs.
Recognized CLSI Evaluation Protocols provide structured approaches for specific performance questions. IMDNA can use these concepts to support study planning, but the laboratory should select and apply guidance appropriate to its own method and requirements.
CLSI EP15 provides a user-verification protocol for precision claims and estimation of bias for quantitative procedures whose performance has already been established. It is intended for verification—not for establishing a new method's full precision performance.
CLSI EP09 addresses measurement-procedure comparison using patient samples and evaluation of bias between quantitative methods. Method comparison should use appropriate samples and statistical analysis rather than relying only on correlation.
CLSI EP17 addresses detection capability, including concepts such as limit of blank, limit of detection, and limit of quantitation. The applicable endpoint depends on whether the method is qualitative or quantitative.
Linearity studies evaluate the relationship between expected concentration and measured response across the relevant measuring interval.
Reference-interval verification or establishment requires a population-appropriate design and should not be treated as a simple instrument check.
Binary-output methods require qualitative performance concepts such as positive/negative agreement, cutoff behavior, and low-level performance rather than quantitative bias alone.
For qPCR and RT-qPCR methods, MIQE 2.0 provides a current research-quality framework that emphasizes assay specificity, amplification efficiency, linearity, dynamic range, controls, detection/quantification limits, normalization, sample handling, and transparent analysis. These principles can complement laboratory-specific verification or validation requirements.
Support in-silico and empirical review of intended target specificity, related sequences, variants, off-target amplification, and assay inclusivity/exclusivity.
Help evaluate efficiency across a defined concentration range and identify assay conditions that may distort quantitative interpretation.
Support dilution-series studies and technical review of the range over which the assay provides meaningful quantitative or qualitative performance.
Support low-level replicate studies and appropriate statistical or empirical approaches where detection or quantification limits are relevant.
Support internal/external control strategy, extraction/process controls, negative controls, positive materials, and evaluation of inhibition or sample-matrix effects.
Help compare multiplex behavior with corresponding singleplex assays and investigate target competition, abundance imbalance, or channel-specific performance differences.
A verification or validation study should not be judged only by whether every result passes. Unexpected findings can provide important information about method limitations, workflow vulnerabilities, matrix effects, or technical variables.
Assess whether controls behaved as expected and whether any control failures could invalidate or qualify the study data.
Help distinguish potentially explainable technical outliers from true method variability and avoid removing data without documented scientific justification.
Review sample identity, comparator limitations, reagent lots, instrument settings, matrix effects, analytical specificity, and other causes of discordant results.
Help investigate why a criterion was not met and whether redesign, optimization, additional data, or method limitation is the appropriate response.
Support organization of deviations, technical impact assessment, corrective work, repeat testing, and study-summary documentation.
Where performance is unstable, support targeted optimization before repeating formal study work rather than simply repeating the same failed design.
IMDNA provides general scientific and technical, assay-development, method-verification, analytical-validation, performance-evaluation, troubleshooting, and non-regulatory implementation support based on the needs of each laboratory organization. Support may include assistance with study planning, draft protocols and worksheets, QC and reference-material support, precision and bias studies, comparison studies, range and detection-capability studies, analytical specificity and interference studies, data review, troubleshooting, assay optimization, documentation support, and technical assistance through implementation.
Where appropriate, IMDNA may also provide general educational information and practical guidance through its scientific, technical, and laboratory-experienced team to help customers understand verification and validation considerations and identify resources relevant to their project.
IMDNA is not a regulatory, licensing, accreditation, certification, legal, or governmental authority. Regulatory approvals, laboratory certification, accreditation, licensing, official inspection, authorization of patient testing, and other official determinations are made only by the applicable authorized organizations and the laboratory's responsible personnel.
Each laboratory is responsible for determining which verification, validation, performance characteristics, quality-control, documentation, personnel, and other requirements apply to its own method and for approving its own study protocols, acceptance criteria, study execution, data interpretation, final conclusions, and authorization of method use.
Any information, draft protocol, technical template, study design, data review, or guidance provided by IMDNA is intended to support the laboratory's scientific and technical work and should not be interpreted as regulatory approval, certification, accreditation, legal determination, reimbursement determination, or a guarantee of regulatory acceptance.
References to governmental, regulatory, accreditation, standards-development, scientific, or professional organizations are provided for general informational purposes only and do not imply endorsement, approval, affiliation, certification, or sponsorship of IMDNA or its services.
The following official and consensus-standard resources support the general concepts of method verification, performance specification establishment, comparison, precision, bias, detection capability, and qPCR performance evaluation. These references are provided for independent educational use and do not imply endorsement of IMDNA or establish one universal study design for every method.
Tell IMDNA about your method, assay type, instrument, specimen, comparator, expected performance, available samples, controls, reference materials, study objectives, and implementation timeline. Our scientific and technical team can help organize a practical study plan covering protocols, materials, precision, comparison, range, sensitivity, specificity, interference, data review, troubleshooting, and implementation support.